Keywords
Prevalence
Adults
Treatment
How to Cite
Copyright © | All rights reserved.
The journal holds the exclusive copyright for the publication of this article under the terms of Brazilian law 9610/98.
Partial reproduction
The use of parts of the texts, figures and questionnaire of the article is free, being mandatory the citation of the authors and journal.
Total reproduction
It is expressly prohibited and must be authorized by the journal.
Abstract
Objective: To identify the main risk factors associated with the occurrence of pharyngotonsillitis in young adults, considering history of infections, previous treatments, and lifestyle habits. Methods: Observational, cross-sectional study conducted with 102 young adults from different university programs in the city of Guarapuava, Paraná. A structured questionnaire based on the Paradise criteria was administered, addressing sex, age, frequency of episodes, type of treatment, alcohol and tobacco consumption, and impacts on daily activities. Data were analyzed using descriptive statistics, with calculation of absolute and relative frequencies. Results: Most participants were female (66.7%) and between 21 and 25 years old (47%). Approximately 36% reported a diagnosis of pharyngotonsillitis in the last three years, with the most common treatment being anti-inflammatory drugs and antibiotics, such as amoxicillin with clavulanate and azithromycin. It was observed that 20.6% were smokers and 73.5% consumed alcoholic beverages. Conclusion: Pharyngotonsillitis in young adults was associated with inappropriate antibiotic use and risky habits, such as smoking and alcohol consumption, highlighting the importance of preventive measures and rational management of the disease.
References
ANDERSEN C, et al. Bacterial findings in patients referred to hospital for the treatment of acute tonsillitis with or without peritonsillar phlegmon. BMC Infect Diseases, 2023; 23(1):439.
ASSOCIAÇÃO BRASILEIRA DE OTORRINOLARINGOLOGIA E CIRURGIA CÉRVICOFACIAL. Tratado de Otorrinolaringologia e Cirurgia Cérvicofacial da ABORL-CCF. São paulo: Elsevier, 2017.
BRAGA CASB, et al. Streptococcus spp. em faringotonsilite aguda recorrente: frequência e perfil de suscetibilidade a antimicrobianos. Revista de Patolologia Tropical, 2015; 44(3): 259–266
CARDOSO DM. Impacto do uso da prova rápida para detecção do estreptococo beta-hemolítico do grupo A no diagnóstico e tratamento da faringotonsilite aguda em pronto-socorro de Pediatria. Revista Paulista de Pediatria, 2013 ; 31(4): 507–512.
CARVILLE KS, et al. Burden of antimicrobial prescribing in primary care attributable to sore throat: a retrospective cohort study of patient record data. BMC Primary Care, 2024; 25(1): 55.
CASEY JR, PICHICHERO ME. Metaanalysis of short course antibiotic treatment for group a streptococcal tonsillopharyngitis. Pediatric Infectious Disease Journal, 2005; 24(10): 909–917.
Centers for Disease Control and Prevention. Clinical Guidance for Group A Streptococcal (GAS) Pharyngitis. 2024.
CINAMON U, et al. The impact of tobacco smoking upon chronic/recurrent tonsillitis and post-tonsillectomy bleeding. International Archives of Otorhinolaryngology, 2017; 21(2): 165–170.
GRANDIN FILHO PG, et al. Agentes etiológicos de faringotonsilites agudas e resistência dos agentes bacterianos aos antimicrobianos em pacientes adultos em São Carlos. São Carlos: Universidade Federal de São Carlos (UFSCar), 2024.
HEDIN K, et al. Different antibiotic treatments for group A streptococcal pharyngitis. Cochrane Database of Systematic Reviews, 2023; 11(11): CD004406.
HOEKELMAN RA, et al. A profile of pediatric practice in United States. American Journal of Diseases of Children, 1983; 137(5): 429–434.
IDSA PRACTICE GUIDELINES. Clinical Practice Guideline Update by the Infectious Diseases Society of America on Group A Streptococcal (GAS) Pharyngitis. Clinical Infectious Diseases, 2025.
JENSEN A, HAGELSKJAER KL. The role of Fusobacterium necrophorum in pharyngotonsillitis: a review. Clinical Microbiology and Infection, 2009; 15(4): 325–332.
KAPLAN EL, et al. Streptococcal pharyngitis and its complications. Clinical Microbiology Reviews, 2009; 22(3): 469–489.
NUNES GSFB, et al. Prevalência das doenças crônicas das amígdalas e adenoides: uma avaliação epidemiológica e clínica. Brazilian Journal of Implantology and Health Sciences, 2024; 6(9): e24561.
PALLON J, SUNDQVIST M, HEDIN K. The use and usefulness of point-of-care tests in patients with pharyngotonsillitis: an observational study in primary health care. BMC Primary Care, 2024; 25(1): 62.
PÉREZ PR, et al. Actualización del documento de consenso sobre el diagnóstico y tratamiento de la faringoamigdalitis aguda. Anales de Pediatría, 2020; 93(3): 221–230.
SHULMAN ST, et al. Diretriz de prática clínica para diagnóstico e tratamento da faringite estreptocócica do grupo A: atualização de 2012 pela Infectious Diseases Society of America. Clinical Infectious Diseases, 2012; 55(10): e86–102.
SOUSA BDM, et al. Análise epidemiológica das internações por faringite aguda e amigdalite aguda em crianças de até 9 anos no Brasil, entre 2019 e 2023. PBPC Journal of Health Sciences, 2024; 8(1): e0123.
SUPPER I, et al. A critical appraisal of acute sore throat guidelines using the AGREE II instrument: a scoping review. Family Practice, 2024; 41(2): 181–192.
TAY RWH, VASOO S. Fusobacterium necrophorum pharyngitis complicated by sepsis and extrapharyngeal dissemination in two young adults. Singapore Medical Journal, 2023; 64(4): 211–214.
VAN DRIEL ML, et al. Different antibiotic treatments for group A streptococcal pharyngitis. Cochrane Database of Systematic Reviews, 2016; 9: CD004406.
WESSELS MR. Diagnosis and Treatment of Pharyngitis in Adults. Infectious Disease Clinics of North America, v. 25, n. 2, p. 335-348, jun. 2011.